Yuan Shiqin, Qi Rui, Fang Xinhe, Wang Xiaoguang, Zhou Liang, Sheng Xunlun
Ningxia Clinical Research Center of Blinding Eye Disease, Ningxia Eye Hospital, People Hospital of Ningxia Hui Autonomous Region (First Affiliated Hospital of Northwest University for Nationalities) , Yinchuan, China.
Aier Eye Hospital Group, Hubin Aier Eye Hospital , Binzhou, Shangdong, China.
Ophthalmic Genet. 2020 Dec;41(6):591-598. doi: 10.1080/13816810.2020.1802762. Epub 2020 Aug 12.
Achromatopsia (ACHM) is an inherited retinal disease affecting the cone cell function. To date, six pathogenic genes of ACHM have been identified. However, the diagnostic and therapeutic methods of this disorder remain limited. Herein, to characterize the clinical features and genetic causes of three affected siblings in a Chinese family with ACHM, we used target next-generation sequencing (NGS) and found new pathogenic factors associated with ACHM in this family. Three patients with ACHM and three healthy family members were included in this study. All participants received comprehensive ophthalmic tests. NGS approach was performed on the patients to determine the causative mutation for this family. The silico analysis was also applied to predict the pathogenesis of identified mutations. Genetic assessments revealed compound heterozygous mutations of the gene (c.1413 + 1 G > C, c.305 G > A), carried by all three patients. Both mutations were novel and predicted to be deleterious by six types of online predictive software. The heterozygous missense mutation (c.305 G > A) was found from the mother and the heterozygous splice site mutation (c.1413 + 1 G > C) was found in the father and all the children. All patients in the family showed typical signs and symptoms of ACHM. We report novel compound heterozygous mutations in causing ACHM and further confirm the clinical diagnosis. Our study extends the genotypic spectrums for -ACHM and better illustrates its genotype-phenotype correlations, which would help the ACHM patients with better genetic diagnosis, prognosis, and gene treatment.
全色盲(ACHM)是一种影响视锥细胞功能的遗传性视网膜疾病。迄今为止,已鉴定出6个导致ACHM的致病基因。然而,这种疾病的诊断和治疗方法仍然有限。在此,为了明确一个患有ACHM的中国家庭中三名患病同胞的临床特征和遗传病因,我们采用了靶向二代测序(NGS)技术,并在该家庭中发现了与ACHM相关的新致病因素。本研究纳入了三名ACHM患者和三名健康家庭成员。所有参与者均接受了全面的眼科检查。对患者进行了NGS检测以确定该家庭的致病突变。还应用了计算机分析来预测已鉴定突变的发病机制。基因评估揭示了三名患者均携带该基因的复合杂合突变(c.1413 + 1 G > C,c.305 G > A)。这两种突变均为新发现的,并且六种在线预测软件均预测它们具有有害性。杂合错义突变(c.305 G > A)来自母亲,杂合剪接位点突变(c.1413 + 1 G > C)在父亲和所有孩子中均被发现。该家庭中的所有患者均表现出ACHM的典型症状和体征。我们报告了导致ACHM的新复合杂合突变,并进一步证实了临床诊断。我们的研究扩展了ACHM的基因型谱,更好地阐明了其基因型与表型的相关性,这将有助于ACHM患者获得更好的基因诊断、预后评估和基因治疗。